Potential role of gastrointestinal microbiota composition in prostate cancer risk

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Amirian, E Susan ^a   Petrosino, Joseph F ^a   Ajami, Nadim J ^a   Liu, Yanhong ^a   Mims, Martha P ^a   Scheurer, Michael E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Human microbiome; Metabolic process; Metagenome; Prostate cancer

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; ENTERITIS; HIGH RISK POPULATION; HUMAN; HYPOTHESIS; INTESTINE FLORA; MICROBIOME; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

EID: 84886743078     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-42     Document Type: Article

References (78)

1. SEER stat fact sheets: prostate [ http://www.seer.cancer.gov/statfacts/ html/prost.html ]
2. History of allergies and autoimmune diseases and risk of brain tumors in adults. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD, Int J Cancer 2002 99 252 259 10.1002/ijc.10320 11979441 (Pubitemid 34309483)
3. Lifestyle and dietary factors in the prevention of lethal prostate cancer. Wilson KM, Giovannucci EL, Mucci LA, Asian J Androl 2012 14 365 374 10.1038/aja.2011.142 22504869
4. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Astorg P, Cancer Causes Control 2004 15 367 386 15141138 (Pubitemid 38988026)
5. Heredity and prostate cancer: a study of World War II veteran twins. Page WF, Braun MM, Partin AW, Caporaso N, Walsh P, Prostate 1997 33 240 245 10.1002/(SICI)1097-0045(19971201)33:4<240::AID-PROS3>3.0.CO;2-L 9397195 (Pubitemid 27524702)
6. Impact of diet on prostate cancer: a review. Sonn GA, Aronson W, Litwin MS, Prostate Cancer Prostatic Dis 2005 8 304 310 10.1038/sj.pcan.4500825 16130015 (Pubitemid 43078163)
7. Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. Punnen S, Hardin J, Cheng I, Klein EA, Witte JS, PLoS One 2011 6 27711 10.1371/journal.pone.0027711 22132129
8. Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study. Major JM, Cross AJ, Watters JL, Hollenbeck AR, Graubard BI, Sinha R, Cancer Causes Control 2011 22 1691 1698 10.1007/s10552-011-9845-1 21971816
9. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM, Cancer Prev Res (Phila) 2011 4 2110 2121 10.1158/1940-6207.CAPR-11-0354 21930800
10. A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer. Alexander DD, Mink PJ, Cushing CA, Sceurman B, Nutr J 2010 9 50 10.1186/1475-2891-9-50 21044319
11. Dairy products and prostate cancer risk. Newmark HL, Heaney RP, Nutr Cancer 2010 62 297 299 10.1080/01635580903407221 20358466
12. Dairy products and cancer. Lampe JW, J Am Coll Nutr 2011 30 464S 470S 10.1080/07315724.2011.10719991 22081693
13. Choline intake and risk of lethal prostate cancer: incidence and survival. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Zeisel SH, Willett WC, Chan JM, Am J Clin Nutr 2012 96 855 863 10.3945/ajcn.112.039784 22952174
14. No association between egg intake and prostate cancer risk: a meta-analysis. Xie B, He H, Asian Pac J Cancer Prev 2012 13 4677 4681 10.7314/APJCP.2012.13.9.4677 23167401
15. Green and black tea intake in relation to prostate cancer risk among Singapore Chinese. Montague JA, Butler LM, Wu AH, Genkinger JM, Koh WP, Wong AS, Wang R, Yuan JM, Yu MC, Cancer Causes Control 2012 23 1635 1641 10.1007/s10552-012-0041-8 22864870
16. Chemoprevention of prostate cancer: natural compounds, antiandrogens, and antioxidants-in vivo evidence. Ozten-Kandas N, Bosland MC, J Carcinog 2011 10 27 10.4103/1477-3163.90438 22190869
17. Dairy products, calcium, and vitamin D and risk of prostate cancer. Chan JM, Giovannucci EL, Epidemiol Rev 2001 23 87 92 10.1093/oxfordjournals.epirev. a000800 11588859 (Pubitemid 32906618)
18. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. Gao X, LaValley MP, Tucker KL, J Natl Cancer Inst 2005 97 1768 1777 10.1093/jnci/dji402 16333032 (Pubitemid 41782286)
19. A prospective study of total and ionized serum calcium and time to fatal prostate cancer. Schwartz GG, Skinner HG, Cancer Epidemiol Biomarkers Prev 2012 21 1768 1773 10.1158/1055-9965.EPI-12-0585 22914529
20. Dairy products, calcium, and prostate cancer risk in the Physicians' health study. Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL, Am J Clin Nutr 2001 74 549 554 11566656 (Pubitemid 32880268)
21. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European prospective investigation into cancer and nutrition study. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, Egevad L, Tjonneland A, Johnsen NF, Overvad K, et al. Am J Clin Nutr 2007 86 672 681 17823432 (Pubitemid 47435834)
22. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Wu K, Erdman JW Jr, Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, DeGroff V, Willett WC, Giovannucci E, Cancer Epidemiol Biomarkers Prev 2004 13 260 269 10.1158/1055-9965.EPI-03-0012 14973107 (Pubitemid 38222558)
23. Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Teodoro AJ, Oliveira FL, Martins NB, Maia GA, Martucci RB, Borojevic R, Cancer Cell Int 2012 12 36 10.1186/1475-2867-12-36 22866768
24. Selenium and prostate cancer: systematic review and meta-analysis. Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, Vieira R, Collings R, Harvey LJ, Sterne JA, et al. Am J Clin Nutr 2012 96 111 122 10.3945/ajcn.111.033373 22648711
25. Update on the relationship of fish intake with prostate, breast, and colorectal cancers. Sala-Vila A, Calder PC, Crit Rev Food Sci Nutr 2011 51 855 871 10.1080/10408398.2010.483527 21888535
26. Problems with the assessment of dietary fat in prostate cancer studies. Dennis LK, Snetselaar LG, Smith BJ, Stewart RE, Robbins ME, Am J Epidemiol 2004 160 436 444 10.1093/aje/kwh243 15321840 (Pubitemid 39166976)
27. Lycopene, tomato products, and prostate cancer incidence: a review and reassessment in the PSA screening Era. Wei MY, Giovannucci EL, J Oncol 2012 2012 271063 22690215
28. Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case-control study. Joshi AD, Corral R, Catsburg C, Lewinger JP, Koo J, John EM, Ingles SA, Stern MC, Carcinogenesis 2012 33 2108 2118 10.1093/carcin/bgs242 22822096
29. Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition. Travis RC, Appleby PN, Siddiq A, Allen NE, Kaaks R, Canzian F, Feller S, Tjonneland A, Fons Johnsen N, Overvad K, et al. Int J Cancer 2012 132 1901 1910 22965418
30. Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk. Amirian ES, Ittmann MM, Scheurer ME, Prostate 2011 71 1382 1389 10.1002/pros.21354 21308720
31. Obesity, metabolic syndrome, and microbiota: multiple interactions. Tilg H, J Clin Gastroenterol 2010 44 Suppl 1 16 S18 20535027
32. Functional interactions between the gut microbiota and host metabolism. Tremaroli V, Backhed F, Nature 2012 489 242 249 10.1038/nature11552 22972297
33. Influence of dietary phytochemicals and microbiota on colon cancer risk. Macdonald RS, Wagner K, J Agric Food Chem 2012 [Epub ahead of print] PMID: 22632581
34. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Musso G, Gambino R, Cassader M, Annu Rev Med 2011 62 361 380 10.1146/annurev-med-012510-175505 21226616
35. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Musso G, Gambino R, Cassader M, Diabetes Care 2010 33 2277 2284 10.2337/dc10-0556 20876708
36. Developing a metagenomic view of xenobiotic metabolism. Haiser HJ, Turnbaugh PJ, Pharmacol Res: J Italian Pharmacol Soc 2013 69 21 31
37. Taking a metagenomic view of human nutrition. Dutton RJ, Turnbaugh PJ, Curr Opin Clin Nutr 2012 15 448 454 10.1097/MCO.0b013e3283561133
38. Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the «second human genome» Akaza H, Cancer Sci 2012 103 969 975 10.1111/j.1349-7006.2012.02257.x 22372745
39. Gut pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes. Saad R, Rizkallah MR, Aziz RK, Gut Pathogens 2012 4 16 10.1186/1757-4749-4-16 23194438
40. Beneficial effects of lactic acid bacteria on human beings. Masood MI, Qadir MI, Shirazi JH, Khan IU, Crit Rev Microbiol 2011 37 91 98 10.3109/1040841X.2010.536522 21162695
41. The gut microbiota as an environmental factor that regulates fat storage. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI, Proc Natl Acad Sci U S A 2004 101 15718 15723 10.1073/pnas.0407076101 15505215 (Pubitemid 39473554)
42. The impact of gut microbes in allergic diseases. Russell SL, Finlay BB, Curr Opin Gastroenterol 2012 28 563 569 10.1097/MOG.0b013e3283573017 23010680
43. Intestinal inflammation targets cancer-inducing activity of the microbiota. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, et al. Science 2012 338 120 123 10.1126/science.1224820 22903521
44. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong ML, Xu A, Chavakis T, Bornstein AB, Ehrhart-Bornstein M, et al. Pharmacogenomics J 2012 doi: 10.1038/tpj.2012.43. [Epub ahead of print] PMID: 23032991
45. Gut microbiota and the immune system: an intimate partnership in health and disease. Iebba V, Nicoletti M, Schippa S, Int J Immunopathol Pharmacol 2012 25 823 833 23298474
46. Invited review: the scientific basis of lactobacillus acidophilus NCFM functionality as a probiotic. Sanders ME, Klaenhammer TR, J Dairy Sci 2001 84 319 331 10.3168/jds.S0022-0302(01)74481-5 11233016
47. Effect of milks inoculated with lactobacillus acidophilus or a yogurt starter culture in lactose-maldigesting children. Montes RG, Bayless TM, Saavedra JM, Perman JA, J Dairy Sci 1995 78 1657 1664 10.3168/jds.S0022-0302(95) 76790-X 8786251
48. Gut microbiota in health and disease. Sekirov I, Russell SL, Antunes LC, Finlay BB, Physiol Rev 2010 90 859 904 10.1152/physrev.00045.2009 20664075
49. Plant secondary metabolites and gut health: the case for Phenolic acids. Russell W, Duthie G, Proc Nutr Soc 2011 70 389 396 10.1017/S0029665111000152 21781364
50. Chemoprevention in experimental animals. Namasivayam N, Ann N Y Acad Sci 2011 1215 60 71 10.1111/j.1749-6632.2010.05873.x 21261642
51. Microbiome and malignancy. Plottel CS, Blaser MJ, Cell host & microbe 2011 10 324 335 10.1016/j.chom.2011.10.003 22018233
52. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ, J Transl Med 2012 10 253 10.1186/1479-5876-10-253 23259758
53. The molecular etiology and prevention of estrogen-initiated cancers. Cavalieri E, Rogan E, Mol Aspects Med 2013 doi: 10.1016/j.mam.2013.08.002. [Epub ahead of print] PMID: 23994691
54. Dietary selenium affects host selenoproteome expression by influencing the gut microbiota. Kasaikina MV, Kravtsova MA, Lee BC, Seravalli J, Peterson DA, Walter J, Legge R, Benson AK, Hatfield DL, Gladyshev VN, FASEB J: Publ Fed Am Soc Exp Biol 2011 25 2492 2499
55. 1H Nuclear magnetic resonance spectroscopy-based studies of the metabolism of food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline by human intestinal microbiota. Humblot C, Combourieu B, Vaisanen ML, Furet JP, Delort AM, Rabot S, Appl Environ Microb 2005 71 5116 5123 10.1128/AEM.71.9.5116- 5123.2005 (Pubitemid 41338238)
56. Beta-glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f] quinoline in rats. Humblot C, Murkovic M, Rigottier-Gois L, Bensaada M, Bouclet A, Andrieux C, Anba J, Rabot S, Carcinogenesis 2007 28 2419 2425 10.1093/carcin/bgm170 17660508 (Pubitemid 350111603)
57. Metabolism of daidzein by fecal bacteria in rats. Rafii F, Jackson LD, Ross I, Heinze TM, Lewis SM, Aidoo A, Lyn-Cook L, Manjanatha M, Comparat Med 2007 57 282 286 (Pubitemid 46981685)
58. Tissue content of mercury in rats given methylmercuric chloride orally: influence of intestinal flora. Rowland IR, Davies MJ, Evans JG, Arch Environ health 1980 35 155 160 10.1080/00039896.1980.10667485 7387196 (Pubitemid 10071824)
59. Analyses of the microbial diversity across the human microbiome. Li K, Bihan M, Yooseph S, Methe BA, PLoS One 2012 7 32118 10.1371/journal.pone.0032118 22719823
60. Our unindicted coconspirators: human metabolism from a microbial perspective. Goodman AL, Gordon JI, Cell Metab 2010 12 111 116 10.1016/j.cmet.2010.07.001 20674856
61. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. Carruba G, J Cell Biochem 2007 102 899 911 10.1002/jcb.21529 17786930 (Pubitemid 350036930)
62. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Commane D, Hughes R, Shortt C, Rowland I, Mutat Res 2005 591 276 289 10.1016/j.mrfmmm.2005.02.027 16095630 (Pubitemid 41654855)
63. Normal to cancer microbiome transformation and its implication in cancer diagnosis. Khan AA, Shrivastava A, Khurshid M, Biochim Biophys Acta 1826 2012 331 337
64. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE, Nat Rev Microbiol 2012 10 575 582 10.1038/nrmicro2819 22728587
65. NIH human microbiome project sampling, sequencing, and analysis protocols [ http://www.hmpdacc.org/tools-protocols/tools-protocols.php ]
66. The human gut microbiome: current knowledge, challenges, and future directions. Dave M, Higgins PD, Middha S, Rioux KP, Transl Res: J Lab Clin Med 2012 160 246 257 10.1016/j.trsl.2012.05.003
67. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Segata N, Haake SK, Mannon P, Lemon KP, Waldron L, Gevers D, Huttenhower C, Izard J, Genome Biol 2012 13 42 10.1186/gb-2012-13-6-r42 22698087
68. Bacterial biogeography of the human digestive tract. Stearns JC, Lynch MD, Senadheera DB, Tenenbaum HC, Goldberg MB, Cvitkovitch DG, Croitoru K, Moreno-Hagelsieb G, Neufeld JD, Sci Rep 2011 1 170 22355685
69. A core human microbiome as viewed through 16S rRNA sequence clusters. Huse SM, Ye Y, Zhou Y, Fodor AA, PLoS One 2012 7 34242 10.1371/journal.pone. 0034242 22719824
70. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB, Infect Immun 2009 77 2367 2375 10.1128/IAI.01520-08 19307217
71. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. Ogino S, Stampfer M, J Natl Cancer Inst 2010 102 365 367 10.1093/jnci/djq031 20208016
72. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Ogino S, Chan AT, Fuchs CS, Giovannucci E, Gut 2011 60 397 411 10.1136/gut.2010.217182 21036793
73. Causal inference in disease ecology: investigating ecological drivers of disease emergence. Plowright RK, Sokolow SH, Gorman ME, Daszak P, Foley JE, Front Ecol Environ 2008 6 420 429 10.1890/070086
74. Biodiversity and functional genomics in the human microbiome. Morgan XC, Segata N, Huttenhower C, Trends Genet 2012 29 51 58 23140990
75. Species-level analysis of DNA sequence data from the NIH human microbiome project. Conlan S, Kong HH, Segre JA, PLoS One 2012 7 47075 10.1371/journal.pone.0047075 23071716
76. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for clostridium difficile and beyond. Vindigni SM, Broussard EK, Surawicz CM, Expert Rev Gastroenterol Hepatol 2013 7 615 628 10.1586/17474124.2013.832501 24070153
77. Fecal microbiota transplantation: past, present and future. Aroniadis OC, Brandt LJ, Curr Opin Gastroenterol 2013 29 79 84 10.1097/MOG.0b013e32835a4b3e 23041678
78. Fecal microbiota transplantation: an innovative approach to treating clostridium difficile disease. Paasche S, JAAPA: J Am Acad Physic Assistants 2013 26 46 49